PDK1 Mediates NOTCH1-mutated Head and Neck Squamous Carcinoma Vulnerability to Therapeutic PI3K/mTOR Inhibition

Clinical Cancer Research - United States
doi 10.1158/1078-0432.ccr-18-3276
Full Text
Abstract

Available in full text

Date
Authors
Publisher

American Association for Cancer Research (AACR)

Related search

Targeting Phosphoinositide 3-Kinase (PI3K) in Head and Neck Squamous Cell Carcinoma (HNSCC)

Cancers of the Head & Neck
2018English

MEK Inhibitor PD-0325901 Overcomes Resistance to PI3K/mTOR Inhibitor PF-5212384 and Potentiates Antitumor Effects in Human Head and Neck Squamous Cell Carcinoma

Clinical Cancer Research
Cancer ResearchOncology
2015English

PD‑L1 Promotes Head and Neck Squamous Cell Carcinoma Cell Growth Through mTOR Signaling

Oncology Reports
MedicineCancer ResearchOncology
2019English

Head and Neck: Oral Squamous Cell Carcinoma

Atlas of Genetics and Cytogenetics in Oncology and Haematology
Cancer ResearchOncologyGeneticsHematology
2011English

Inhibition of PI3K and MEK in Combination With Radiation Therapy in Murine Model of Head and Neck Squamous Cell Carcinoma (HNSCC)

International Journal of Radiation Oncology Biology Physics
OncologyRadiologyCancer ResearchRadiationNuclear MedicineImaging
2016English

Enhanced Therapeutic Radiosensitization by Targeting EphB4 Receptor in Head and Neck Squamous Cell Carcinoma

International Journal of Radiation Oncology Biology Physics
OncologyRadiologyCancer ResearchRadiationNuclear MedicineImaging
2016English

Head and Neck Squamous Cell Carcinoma Survivorship Care

2019English

Immunotherapy for Head and Neck Squamous Cell Carcinoma

Memo - Magazine of European Medical Oncology
OncologyHematology
2016English

Inhibition of Caspase-9 Activity in Cisplatin-Resistant Head and Neck Squamous Cell Carcinoma.

Journal of Otolaryngology of Japan
Otorhinolaryngology
2002English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy